Cargando…
Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia
Aberrant activation of the NOTCH signaling pathway is crucial for the onset and progression of T cell leukemia. Yet recent studies also suggest a tumor suppressive role of NOTCH signaling in acute myeloid leukemia (AML) and reactivation of this pathway offers an attractive opportunity for anti-AML t...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876435/ https://www.ncbi.nlm.nih.gov/pubmed/27211848 http://dx.doi.org/10.1038/srep26510 |
_version_ | 1782433236278837248 |
---|---|
author | Ye, Qi Jiang, Jue Zhan, Guanqun Yan, Wanyao Huang, Liang Hu, Yufeng Su, Hexiu Tong, Qingyi Yue, Ming Li, Hua Yao, Guangmin Zhang, Yonghui Liu, Hudan |
author_facet | Ye, Qi Jiang, Jue Zhan, Guanqun Yan, Wanyao Huang, Liang Hu, Yufeng Su, Hexiu Tong, Qingyi Yue, Ming Li, Hua Yao, Guangmin Zhang, Yonghui Liu, Hudan |
author_sort | Ye, Qi |
collection | PubMed |
description | Aberrant activation of the NOTCH signaling pathway is crucial for the onset and progression of T cell leukemia. Yet recent studies also suggest a tumor suppressive role of NOTCH signaling in acute myeloid leukemia (AML) and reactivation of this pathway offers an attractive opportunity for anti-AML therapies. N-methylhemeanthidine chloride (NMHC) is a novel Amaryllidaceae alkaloid that we previously isolated from Zephyranthes candida, exhibiting inhibitory activities in a variety of cancer cells, particularly those from AML. Here, we report NMHC not only selectively inhibits AML cell proliferation in vitro but also hampers tumor development in a human AML xenograft model. Genome-wide gene expression profiling reveals that NMHC activates the NOTCH signaling. Combination of NMHC and recombinant human NOTCH ligand DLL4 achieves a remarkable synergistic effect on NOTCH activation. Moreover, pre-inhibition of NOTCH by overexpression of dominant negative MAML alleviates NMHC-mediated cytotoxicity in AML. Further mechanistic analysis using structure-based molecular modeling as well as biochemical assays demonstrates that NMHC docks in the hydrophobic cavity within the NOTCH1 negative regulatory region (NRR), thus promoting NOTCH1 proteolytic cleavage. Our findings thus establish NMHC as a potential NOTCH agonist that holds great promises for future development as a novel agent beneficial to patients with AML. |
format | Online Article Text |
id | pubmed-4876435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48764352016-06-06 Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia Ye, Qi Jiang, Jue Zhan, Guanqun Yan, Wanyao Huang, Liang Hu, Yufeng Su, Hexiu Tong, Qingyi Yue, Ming Li, Hua Yao, Guangmin Zhang, Yonghui Liu, Hudan Sci Rep Article Aberrant activation of the NOTCH signaling pathway is crucial for the onset and progression of T cell leukemia. Yet recent studies also suggest a tumor suppressive role of NOTCH signaling in acute myeloid leukemia (AML) and reactivation of this pathway offers an attractive opportunity for anti-AML therapies. N-methylhemeanthidine chloride (NMHC) is a novel Amaryllidaceae alkaloid that we previously isolated from Zephyranthes candida, exhibiting inhibitory activities in a variety of cancer cells, particularly those from AML. Here, we report NMHC not only selectively inhibits AML cell proliferation in vitro but also hampers tumor development in a human AML xenograft model. Genome-wide gene expression profiling reveals that NMHC activates the NOTCH signaling. Combination of NMHC and recombinant human NOTCH ligand DLL4 achieves a remarkable synergistic effect on NOTCH activation. Moreover, pre-inhibition of NOTCH by overexpression of dominant negative MAML alleviates NMHC-mediated cytotoxicity in AML. Further mechanistic analysis using structure-based molecular modeling as well as biochemical assays demonstrates that NMHC docks in the hydrophobic cavity within the NOTCH1 negative regulatory region (NRR), thus promoting NOTCH1 proteolytic cleavage. Our findings thus establish NMHC as a potential NOTCH agonist that holds great promises for future development as a novel agent beneficial to patients with AML. Nature Publishing Group 2016-05-23 /pmc/articles/PMC4876435/ /pubmed/27211848 http://dx.doi.org/10.1038/srep26510 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Ye, Qi Jiang, Jue Zhan, Guanqun Yan, Wanyao Huang, Liang Hu, Yufeng Su, Hexiu Tong, Qingyi Yue, Ming Li, Hua Yao, Guangmin Zhang, Yonghui Liu, Hudan Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia |
title | Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia |
title_full | Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia |
title_fullStr | Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia |
title_full_unstemmed | Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia |
title_short | Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia |
title_sort | small molecule activation of notch signaling inhibits acute myeloid leukemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876435/ https://www.ncbi.nlm.nih.gov/pubmed/27211848 http://dx.doi.org/10.1038/srep26510 |
work_keys_str_mv | AT yeqi smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT jiangjue smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT zhanguanqun smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT yanwanyao smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT huangliang smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT huyufeng smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT suhexiu smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT tongqingyi smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT yueming smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT lihua smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT yaoguangmin smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT zhangyonghui smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia AT liuhudan smallmoleculeactivationofnotchsignalinginhibitsacutemyeloidleukemia |